tiprankstipranks
Trending News
More News >
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market
Advertisement

Ikena Oncology (IKNA) Technical Analysis

Compare
103 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Ikena Oncology’s (IKNA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Ikena Oncology is a Sell.
Ikena Oncology’s (IKNA) 20-Day exponential moving average is 1.34, while Ikena Oncology’s (IKNA) share price is $1.37, making it a Buy.
Ikena Oncology’s (IKNA) 50-Day exponential moving average is 1.32, while Ikena Oncology’s (IKNA) share price is $1.37, making it a Buy.

Ikena Oncology (IKNA) Pivot Points

Jul 26, 2025, 01:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.23
1.26
1.32
1.35
1.41
1.44
1.50
Fibonacci
1.26
1.30
1.32
1.35
1.39
1.41
1.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ikena Oncology (IKNA) Moving Averages

Jul 26, 2025, 01:34 PM
Period
Simple
Exponential
MA5
1.34Buy
1.36Buy
MA10
1.33Buy
1.34Buy
MA20
1.34Buy
1.34Buy
MA50
1.30Buy
1.32Buy
MA100
1.27Buy
1.33Buy
MA200
1.44Sell
1.45Sell
Ikena Oncology’s (IKNA) 10-Day exponential moving average is 1.34, while Ikena Oncology’s (IKNA) share price is $1.37, making it a Buy.
Ikena Oncology’s (IKNA) 100-Day exponential moving average is 1.33, while Ikena Oncology’s (IKNA) share price is $1.37, making it a Buy.
Ikena Oncology’s (IKNA) stock price is $1.37 and Ikena Oncology’s (IKNA) 50-day simple moving average is 1.30, creating a Buy signal.
Ikena Oncology’s (IKNA) stock price is $1.37 and Ikena Oncology’s (IKNA) 100-day simple moving average is 1.27, creating a Buy signal.
Ikena Oncology’s (IKNA) stock price is $1.37 and Ikena Oncology’s (IKNA) 200-day simple moving average is 1.44, creating a Sell signal.

Ikena Oncology (IKNA) Technical Indicators

Jul 26, 2025, 01:34 PM
Name
Value
Implied Action
RSI (14)
59.82
Neutral
STOCH (9,6)
70.69
Neutral
STOCHRSI (14)
70.69
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
26.03
Neutral
Williams %R
-17.56
Sell
CCI (14)
147.90
Sell
ATR (14)
0.08
-
Ultimate Oscillator
58.13
Neutral
ROC
5.93
Buy
Ikena Oncology’s (IKNA) Relative Strength Index (RSI) is 59.82, creating a Neutral signal.
Ikena Oncology’s (IKNA) Trend Strength Indicator (ADX) is 26.03, creating a Neutral signal.
Ikena Oncology’s (IKNA) Commodity Channel Index (CCI) is 147.90, creating a Sell signal.
Ikena Oncology’s (IKNA) Price Rate of Change (ROC) is 5.93, creating a Buy signal.

FAQ

Is IKNA a Buy, Hold, or Sell?
Based on IKNA’s technical indicators, IKNA is a Buy.
    What is IKNA’s RSI (14)?
    IKNA’s RSI (14) is 59.82, which suggests IKNA is a Neutral.
      What is IKNA’s MACD?
      IKNA’s MACD is <0.01, which suggests IKNA is a Sell.
        What is IKNA’s 5-day moving average?
        IKNA’s 5-day moving average is 1.34, which suggests IKNA is a Buy.
          What is IKNA’s 20-day moving average?
          IKNA 20-day moving average is 1.34, which suggests IKNA is a Buy.
            What is IKNA’s 50-day moving average?
            IKNA’s 50-day moving average is 1.30, which suggests IKNA is a Buy.
              What is IKNA’s 200-day moving average?
              IKNA’s 200-day moving average is 1.44, which suggests IKNA is a Sell.
                What is IKNA’s Williams % R (14)?
                IKNA’s Williams % R (14) is -17.56, which suggests IKNA is a Sell.
                  What is IKNA’s CCI (14)?
                  IKNA’s CCI (14) is 147.90, which suggests IKNA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis